Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
OrthoPediatrics Corp (KIDS)
NASDAQ:KIDS
KIDS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$21.02 - $35.99
Previous CloseN/A
Volume20.12K
Average Volume (3M)318.66K
Market Cap
$589.90M
Enterprise Value$626.52M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.39
Next Earnings
Mar 04, 2025EPS Estimate
-0.3Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.24
Shares Outstanding24,215,937
10 Day Avg. Volume281,790
30 Day Avg. Volume318,658
Standard Deviation0.12
R-Squared0.26
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)3.11
Price to Cash Flow (P/CF)-14.40
P/FCF Ratio0.00
Enterprise Value/Market Cap1.06
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit5.63
Enterprise Value/Ebitda-40.60
Forecast
1Y Price Target
$40.67Price Target Upside66.95% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
---
OrthoPediatrics News
PremiumCompany Announcements
OrthoPediatrics Highlights Growth Strategy in Presentations
---
Bulls Say, Bears Say
Bulls Say
Growth StrategyOrthoPediatrics' new Boston O&P clinic strategy presents an opportunity for significant growth acceleration.
Market PotentialKIDS foresees a $500 mln TAM in the pediatric O&P business, with potential for additional market capture depending on new bracing product releases.
Sales PerformanceOrthoPediatrics preannounced 4Q24 revenue of $52.7M, which was above consensus of $50.7M, indicating strong sales performance.
Bears Say
Earnings GuidanceAdjusted EBITDA guidance is lower than consensus, at $15-17M versus $20.1M, which might affect investor confidence.
Financial GuidanceThe initial 2025 sales guidance and adjusted EBITDA target are both below Street numbers, which may concern investors.
Operational ChallengesCOVID-19 and its lingering headwinds, along with RSV, have negatively impacted the business, leading to procedural deferrals and staffing issues.
---
Ownership Overview
32.45% Insiders
18.10% Mutual Funds
25.67% Other Institutional Investors
15.25% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
KIDS FAQ
What was OrthoPediatrics Corp’s price range in the past 12 months?
OrthoPediatrics Corp lowest stock price was $21.02 and its highest was $35.99 in the past 12 months.
What is OrthoPediatrics Corp’s market cap?
OrthoPediatrics Corp’s market cap is $589.90M.
When is OrthoPediatrics Corp’s upcoming earnings report date?
OrthoPediatrics Corp’s upcoming earnings report date is Mar 04, 2025 which is in 10 days.
How were OrthoPediatrics Corp’s earnings last quarter?
OrthoPediatrics Corp released its earnings results on Nov 06, 2024. The company reported -$0.18 earnings per share for the quarter, beating the consensus estimate of -$0.227 by $0.047.
Is OrthoPediatrics Corp overvalued?
According to Wall Street analysts OrthoPediatrics Corp’s price is currently Undervalued.
Does OrthoPediatrics Corp pay dividends?
OrthoPediatrics Corp does not currently pay dividends.
What is OrthoPediatrics Corp’s EPS estimate?
OrthoPediatrics Corp’s EPS estimate is -0.3.
How many shares outstanding does OrthoPediatrics Corp have?
OrthoPediatrics Corp has 24,215,937 shares outstanding.
What happened to OrthoPediatrics Corp’s price movement after its last earnings report?
OrthoPediatrics Corp reported an EPS of -$0.18 in its last earnings report, beating expectations of -$0.227. Following the earnings report the stock price went down -11.179%.
Which hedge fund is a major shareholder of OrthoPediatrics Corp?
Currently, no hedge funds are holding shares in KIDS
---
OrthoPediatrics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$40.67 (66.95% Upside)
$40.67 (66.95% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-15.38%
12-Months-Change
Fundamentals
Return on Equity
-7.63%
Trailing 12-Months
Asset Growth
13.15%
Trailing 12-Months
Company Description
OrthoPediatrics Corp
OrthoPediatrics Corp. is a medical device company, which engages in the design, development, and marketing of anatomically appropriate implants and devices for children with orthopedic conditions. Its products includes PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, RESPONSE Spine, Bandloc and Pediguard. The company was founded by Erin Springer Yount and Nick A. Deeter in August 2006 and is headquartered in Warsaw, IN.
---
KIDS Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted strong revenue growth and increased guidance, with significant achievements in scoliosis and international markets. However, challenges such as decreased gross margins and increased operating expenses were noted. The overall sentiment is positive due to robust revenue growth and strategic advancements, despite some operational challenges.Read More>---
KIDS Stock 12 Month Forecast
Average Price Target
$40.67
▲(66.95% Upside)
Technical Analysis
Best Analysts Covering KIDS
1 Year
1 Year Success Rate
7/28 ratings generated profit
1 Year Average Return
-13.60%
reiterated a buy rating last month
Copying Michael Matson's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -13.60% per trade.
---